New Zealand markets close in 6 hours 46 minutes

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
187.27+1.89 (+1.02%)
At close: 04:00PM EDT
188.00 +0.73 (+0.39%)
After hours: 07:09PM EDT

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000

IndustryMedical Devices
Full-time employees3,000

Key executives

NameTitlePayExercisedYear born
Dr. James R. Hollingshead Ph.D.President, CEO & Director2.88MN/A1963
Ms. Lauren BuddenGroup VP, Chief Accounting Officer & Controller794.05kN/A1975
Mr. Mark FieldSenior VP & CTO954.14kN/A1971
Mr. John Wodick KapplesSenior VP & General Counsel1.02MN/A1960
Ms. Shacey PetrovicDirector & Advisor28.57kN/A1973
Mr. Eric BenjaminExecutive VP, Chief Product & Customer Experience Officer1.14MN/A1983
Ms. Ana Maria ChadwickExecutive VP, CFO & TreasurerN/AN/A1972
Mr. Prem SinghSenior Vice President of Global OperationsN/AN/A1977
Ms. Deborah R. Gordon CPAVice President of Investor RelationsN/AN/A1971
Ms. Laetitia CousinSenior VP of Regulatory Affairs, Quality Assurance & ComplianceN/AN/A1976
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Corporate governance

Insulet Corporation’s ISS governance QualityScore as of 1 May 2024 is 9. The pillar scores are Audit: 7; Board: 8; Shareholder rights: 10; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.